Journal of Endourology · 2007 · 23 citations · 6 references
MedicineSurgeryUrologyProstate DiseaseUrogenital SurgeryUrologic SurgeryBenign Prostatic HyperplasiaBenign Prostatic Hyperplasia SurgeryBladder Outlet ObstructionProstate SurgeryStent PlacementUrinary Tract Obstruction SurgeryBenign Prostatic Hyperplasia-associated RetentionBenign Prostatic Hyperplasia-related RetentionBladder Outlet Obstruction SurgeryFunctional Bladder Outlet ObstructionLong-term CatheterizationPostoperative StentingProstatic Obstruction
BACKGROUND: Prostatic stents offer a third clinical option for patients with bladder-outlet obstruction who are unfit for surgical relief and wish to avoid long-term catheterization. We report our experience with the Abbey-Moor Spanner temporary prostatic stent in patients with acute and chronic symptoms of bladder-outlet obstruction secondary to benign or malignant disease who were unfit for surgery because of age or cardiorespiratory disease. PATIENTS AND METHODS: A series of 43 consecutive patients stented March 2004 through November 2005 were reviewed retrospectively. Stents were removed and replaced every 3 months if tolerated. RESULTS: More than half of the patients (63%) had an unsatisfactory outcome, namely, immediate or delayed retention or elective removal because of unbearable symptoms. The remaining 37% of patients had a satisfactory outcome and either continue to have the stent in situ after a mean of five changes or are stent free after a successful voiding trial. CONCLUSION: Only 21% of the patients in whom stenting was indicated continued to have a stent in situ at the end of the study. We suggest that in such patients, a temporary stent such as the AbbeyMoor Spanner should be used for only 3 months as a trial of stenting followed by a trial of stent-free voiding, with the patient converted to permanent prostatic stenting if voiding is unsuccessful.
6
P. Rigatti, Maurizio Brausi, Roberto Mario Scarpa et al. · Prostate Cancer and Prostatic Diseases · 2003 · 33 citations
Medicine, Pharmacotherapy, Urology +10